GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,477,000 | +115.0% | 124,483 | +0.9% | 0.56% | +128.7% |
Q2 2022 | $3,943,000 | -13.3% | 123,415 | -6.0% | 0.24% | +0.8% |
Q1 2022 | $4,550,000 | +28.5% | 131,351 | +8.6% | 0.24% | +39.1% |
Q4 2021 | $3,541,000 | +9.4% | 120,966 | -4.8% | 0.17% | +2.4% |
Q3 2021 | $3,237,000 | -23.8% | 127,045 | +4.8% | 0.17% | -24.8% |
Q2 2021 | $4,246,000 | -8.3% | 121,257 | +6.7% | 0.23% | -18.7% |
Q1 2021 | $4,630,000 | – | 113,630 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |